Alexander Gerhard Miethke

Alexander Gerhard Miethke

Auto-generated profile, based on publicly available information

Alexander Gerhard Miethke

Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2015 in Hepatology
Verified
Journal Article
Open access
PDF file
AMAlexander G. Miethke
Alexander G. Miethke
WZWujuan Zhang
Wujuan Zhang
JSJulia Simmons
Julia Simmons
ATAmy E. Taylor
Amy E. Taylor
TSTiffany Shi
Tiffany Shi
KSKenneth D.R. Setchell
Kenneth D.R. Setchell
Deficiency of multidrug resistance 2 (mdr2), a canalicular phospholipid floppase, leads to excretion of low‐phospholipid “toxic” bile causing progressive cholestasis. We hypothesize that pharmacological inhibition of the ileal, apical sodium‐dependent bile acid transporter (ASBT), blocks progression of sclerosing cholangitis in mdr2–/– mice. Thirty‐day‐old, female mdr2–/– mice were fed high‐fat chow containing 0.006% SC‐435, a minimally absorbed, potent inhibitor of ASBT, providing, on average, 11 mg/kg/day of compound. Bile acids (BAs) and phospholipids were measured by mass spectrometry. Compared with untreated mdr2–/– mice, SC‐435 treatment for 14 days increased fecal BA excretion by 8‐fold, lowered total BA concentration in liver by 65%, reduced total BA and individual hydrophobic BA concentrations in serum by >98%, and decreased plasma alanine aminotransferase, total bilirubin, and serum alkaline phosphatase levels by 86%, 93%, and 55%, respectively. Liver histology of sclerosing cholangitis improved, and extent of fibrosis decreased concomitant with reduction of hepatic profibrogenic gene expression. Biliary BA concentrations significantly decreased and phospholipids remained low and unchanged with treatment. The phosphatidylcholine (PC)/BA ratio in treated mice corrected toward a ratio of 0.28 found in wild‐type mice, indicating decreased bile toxicity. Hepatic RNA sequencing studies revealed up‐regulation of putative anti‐inflammatory and antifibrogenic genes, including Ppara and Igf1, and down‐regulation of several proinflammatory genes, including Ccl2 and Lcn2, implicated in leukocyte recruitment. Flow cytometric analysis revealed significant reduction of frequencies of hepatic CD11b+F4/80+ Kupffer cells and CD11b+Gr1+ neutrophils, accompanied by expansion of anti‐inflammatory Ly6C– monocytes in treated mdr2–/– mice. Conclusion: Inhibition of ASBT reduces BA pool size and retention of hydrophobic BA, favorably alters the biliary PC/BA ratio, profoundly changes the hepatic transcriptome, attenuates recruitment of leukocytes, and abrogates progression of murine sclerosing cholangitis. (Hepatology 2016;63:512–523)

1 November 2012 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
BSBenjamin L. Shneider
Benjamin L. Shneider
BABob Abel
Bob Abel
BHBarbara Haber
Barbara Haber
SKSaul J. Karpen
Saul J. Karpen
JMJohn C. Magee
John C. Magee
C(Childhood Liver Disease Research and Education Network (ChiLDREN)
Childhood Liver Disease Research and Education Network (ChiLDREN)

6 May 2024 in The Lancet Gastroenterology & Hepatology
Verified
Journal Article
Closed access
AMAlexander G Miethke
Alexander G Miethke
AMAdib Moukarzel
Adib Moukarzel
GPGilda Porta
Gilda Porta
JEJoshue Covarrubias Esquer
Joshue Covarrubias Esquer
PCPiotr Czubkowski
Piotr Czubkowski
RTRichard J Thompson
Richard J Thompson

1 May 2010 in Journal of Hepatology
Verified
Journal Article
Closed access
AMAlexander G. Miethke
Alexander G. Miethke
VSVijay Saxena
Vijay Saxena
PSPranavkumar Shivakumar
Pranavkumar Shivakumar
GSGregg E. Sabla
Gregg E. Sabla
JSJulia Simmons
Julia Simmons
CCClaire A. Chougnet
Claire A. Chougnet

19 September 2016 in Hepatology
Verified
Journal Article
Open access
PDF file
CLCeline S. Lages
Celine S. Lages
JSJulia Simmons
Julia Simmons
AMAvery Maddox
Avery Maddox
KJKeaton Jones
Keaton Jones
RKRebekah Karns
Rebekah Karns
AMAlexander G. Miethke
Alexander G. Miethke
Biliary atresia (BA) is a fibroinflammatory obstruction of the extrahepatic biliary tree in neonates. While intrahepatic bile duct proliferation is universal at diagnosis, bile duct paucity develops later. We hypothesized that polarized T helper lymphocyte responses orchestrate progression of intrahepatic biliary injury in this disease. Interleukin 17A (IL-17A)-green fluorescent protein, cluster of differentiation 11c (CD11c)/diphtheria toxin receptor, and IL-17 receptor A−/− mice were used to examine T-lymphocyte polarization, inflammatory leukocyte recruitment, and biliary injury in rhesus rotavirus–induced BA. Multiparameter flow cytometry and automated image analysis of immunostaining were applied to liver tissue samples from infants with BA. In the mouse model, activated CD4+ lymphocytes started to emerge in the liver on day 8 after viral challenge, while innate immune responses were waning. Plasma IL-17A levels rose concomitantly with hepatic accumulation of T helper 17 lymphocytes and myeloid dendritic cells. Targeted depletion of CD11c+ dendritic cells diminished hepatic IL-17A production and ameliorated intrahepatic bile duct injury. Recombinant IL-17A induced expression of chemokine (C-C motif) ligand 2 in neonatal cholangiocytes in vitro, and blockade of the corresponding chemokine (C-C motif) receptor 2 reduced recruitment of inflammatory macrophages to the liver in vivo. Genetic disruption of IL-17A signaling was associated with down-regulation of hepatic Ccl2/Ccr2 messenger RNA expression, reduced infiltration of the liver with inflammatory Ly6Chi macrophages, and improved survival. In the liver of infants with BA, cholangiocytes were found to express IL-17 receptor A, and the prevalence of IL-17A+ cells was positively correlated with the degree of CD68+ macrophage infiltration at diagnosis. Hepatic CD4+ lymphocytes were chief producers of IL-17A in patients with progressive disease undergoing liver transplantation. Conclusion: These findings identify the dendritic cell–T helper 17–macrophage axis as a target for the development of strategies to block progression of intrahepatic bile duct injury in patients with BA. (Hepatology 2017;65:174-188).

15 February 2012 in Hepatology
Verified
Journal Article
Open access
PDF file
CLCeline S. Lages
Celine S. Lages
JSJulia Simmons
Julia Simmons
CCClaire A. Chougnet
Claire A. Chougnet
AMAlexander G. Miethke
Alexander G. Miethke
CD8 T-lymphocytes are effector cells of cholangiocyte injury in human and in rhesus rotavirus (RRV)-induced experimental biliary atresia (BA). Here we hypothesize that neonatal deficiency in CD25+CD4+ regulatory T cells (Tregs) leads to aberrant activation of hepatic T-lymphocytes in BA. We found that adoptive transfer of total CD4 cells, but not of CD25-depleted CD4 cells, prior to RRV inoculation reduced expansion of CD8 cells, plasma bilirubin levels, ductal inflammation, and bile duct epithelial injury at 7 days postinfection (dpi) compared with age-matched infected controls without adoptive transfer. Searching for mechanisms, we found that in vitro production of interferon-gamma (IFN-γ) by naïve CD8 cells upon polyclonal stimulation was enhanced in coculture with hepatic dendritic cells (DCs) from RRV-infected, but not with DCs from noninfected mice, which was correlated with an increased proportion of CD11b+ myeloid (m)DCs and up-regulation of the costimulatory molecule CD86 on RRV-primed DCs. Furthermore, DC-dependent T-lymphocyte activation was blocked by anti-CD86 antibody in dose-dependent fashion. Importantly, expression of CD86 on mDCs was down-regulated by Tregs in vitro, and adoptive transfer of Treg-containing CD4 cells decreased expression of CD86 on hepatic mDCs at 7 dpi. On the contrary, in mice resistant to experimental BA, CD25+ cell depletion aggravated bile duct injury at 12 dpi after RRV inoculation, as plasma bilirubin levels were elevated by >20-fold compared with nondepleted infected controls. Increased susceptibility to hepatobiliary injury in Treg-depleted mice was linked to hepatic CD8 expansion and enhanced stimulatory capacity of hepatic DCs. Conclusion: Activation of hepatic T-lymphocytes driving biliary obstruction in BA is regulated by mDCs by way of CD86-dependent costimulation and is susceptible to inhibition by Tregs. (HEPATOLOGY 2012;56:219–227)